LEIDOS BIOMEDICAL RESEARCH INC: $372M Department of Health and Human Services Contract
Summary
Leidos Holdings ($LDOS) wins a $372M task order from NIH for NCI operations, adding ~2.4% to annual revenue. The award is a routine renewal under an existing contract, providing stable cash flow but no transformative catalyst.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Leidos adds $372M to its backlog, representing ~2.4% of annual revenue.
- 2.The award is a routine renewal under an existing NIH contract, not a new program.
- 3.No direct legislative catalyst; funding comes from NIH appropriations.
Market Implications
For Leidos, this contract is a positive but expected development. The stock is already priced for steady government contracting, so the award is unlikely to drive significant price movement. It confirms the company's reliable cash flow from health IT and research support. No other publicly traded companies are directly impacted.
Full Analysis
The Department of Health and Human Services, through the National Institutes of Health, awarded Leidos Biomedical Research Inc a $372M delivery order for NCI operational support covering FY2026-FY2027. This is a task order under an existing contract, indicating continued partnership rather than new business. Leidos Holdings is the publicly traded parent, with FY2025 revenue of $15.3B. The $372M represents 2.4% of annual revenue, a meaningful but not transformative addition. No specific legislation is directly tied to this award; it is funded through NIH's base appropriations. Supply chain beneficiaries are likely small businesses in health IT and laboratory services, but no publicly traded subcontractors are identified. Historically, Leidos has consistently won large NIH contracts, and this award continues that pattern without shifting competitive dynamics.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
LEIDOS BIOMEDICAL RESEARCH INC: $342M Department of Health and Human Services Contract
LEIDOS, INC.: $18.8M Department of Homeland Security Contract
CACI, INC. - FEDERAL: $487M Department of Homeland Security Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
The National Space Transportation Policy
This memorandum directs multiple agencies to expand and modernize U.S. space launch and reentry infrastructure to support over 1,000 launches annually by 2030, expedite permitting and environmental reviews, develop new federal reentry sites, and strengthen the space transportation industrial base. It mandates range scheduling transparency, spectrum reliability, and workforce development, with specific reports and plans due within 90 to 240 days.
Adjusting Imports of Unmanned Aircraft Systems and Unmanned Aircraft Systems Components into the United States
This proclamation imposes a 100% ad valorem tariff on imports of unmanned aircraft systems (UAS) over 25 kg, those with thermal imagers, docking stations, and certain components, and a 25% tariff on UAS under 25 kg and other components, citing national security under Section 232 of the Trade Expansion Act. It also authorizes the Department of Commerce to establish an onshoring program offering preferential tariff treatment for companies that build new U.S. manufacturing facilities for UAS and components.
Expanding Capabilities to Combat Transnational Cyber-Enabled Crime
This memorandum establishes a government program, managed by the National Coordination Center (NCC), that authorizes private companies to conduct cyber surveillance and operations against foreign cyber-enabled transnational criminal organizations under federal oversight. It directs the Department of Justice and Department of Homeland Security to co-execute the program, requiring vetted companies to enter contracts with the government and potentially post a $1 million bond, with implementation guidance to be developed within 60 days.
Contract Details
Recipient
LEIDOS BIOMEDICAL RESEARCH INC
Award Amount
$371,787,375
Awarding Agency
Department of Health and Human Services
Sub-Agency
National Institutes of Health
Contract Type
DELIVERY ORDER
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →